[HTML][HTML] Safety and target engagement of complement C1q inhibitor ANX007 in neurodegenerative eye disease: results from phase I studies in glaucoma
Purpose Complement C1q, the initiating molecule of the classical complement cascade, is
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma
Y Sun, D Wirta, W Murahashi, V Mathur… - Ophthalmology …, 2023 - europepmc.org
Purpose Complement C1q, the initiating molecule of the classical complement cascade, is
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
[HTML][HTML] Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma
Y Sun, D Wirta, W Murahashi… - Ophthalmology …, 2023 - ophthalmologyscience.org
Purpose Complement C1q, the initiating molecule of the classical complement cascade, is
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
[HTML][HTML] Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma
Y Sun, D Wirta, W Murahashi, V Mathur… - Ophthalmology …, 2023 - ncbi.nlm.nih.gov
Purpose Complement C1q, the initiating molecule of the classical complement cascade, is
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma
Y Sun, D Wirta, W Murahashi… - Ophthalmology …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Complement C1q, the initiating molecule of the classical complement cascade, is
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma.
Y Sun, D Wirta, W Murahashi, V Mathur… - Ophthalmology …, 2023 - europepmc.org
Purpose Complement C1q, the initiating molecule of the classical complement cascade, is
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …
involved in synapse elimination and neuronal loss in neurodegenerative diseases including …